4Coambs RB, et al. Review of the scientific Literature on the prevalence, consequences and health costs of noncompliance & inappropriate use of prescription medication in Canada: health promotion research[ M ]. University of Toronto Press, 1995: 76.
5Morisky DE, et al. Concurrent and predictive validity of a self-reported measure of medication adherence[J]. Med Ca re, 1986, 24(1) :67 - 74.
6中国高血压联盟.中国高血压防治指南[M](试行本).3
7Shea S, et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am[J ]. J Public Health. 1992,82(12): 1607 - 1612.
8Monane M, et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race[ J ].Am. J Public Health, 1996, 86(12): 1805 - 1808.
9Darnell JC, et al. Medication use by ambulatory elderly:an in-home survey[ J ]. J Am Geriatr Soc, 1986, 34:1 - 4.
6Parchman ML,Zeber JE,Palmer RF.Participatory decision making,patient activation,medication adherence,and intermediate clinical outcomes in type 2 diabetes:a STARNet study[J].Ann Fam Med,2010,8(5):410-417.
7Piette JD,Heisler M,Home R,et al.A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures[J].Soc Sci Med,2006,62 (4):846-857.
8Mackey K,Parchman ML,Leykum LK,et al.Impact of the Chronic Care Model on medication adherence when patients perceive cost as a barrier[J].Prim Care Diabetes,2012,6(2):137-142.
9Austin B,Wagner E,Hindmarsh M,et al.Elements of Effective Chronic Care:A Model for Optimizing Outcomes for the Chronically Ⅲ[J].Epilepsy Behav,2000,1 (4):S15-S20.
